Search research articles
Contact Us
Filters
Showing results (81-90 of 155) with videos related to
Page
of 16
Sort By:
Oncotarget
|
August 27, 2015
Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting
Veerakumar Balasubramaniyan, Brian Vaillant, Shuzhen Wang, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
NG2-targeting macrophages inhibit 3D invasion of patient-derived glioblastoma spheroids
Elena Kurudza, Sophia R S Varady, Daniel Greiner, et al.
Journal of Neuro-Oncology
|
August 31, 2012
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme
Kenneth F Grossmann, Howard Colman, Wallace A Akerley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2006
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma
Christopher E Pelloski, E Lin, Li Zhang, et al.
Stem Cell Research & Therapy
|
October 17, 2015
Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism
Shuqiang Yuan, Yunxin Lu, Jing Yang, et al.
Cancer Cell
|
October 22, 2011
FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis
Nu Zhang, Ping Wei, Aihua Gong, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 29, 2024
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors
Xuefeng Wang, Tingyi Li, Islam Eljilany, et al.
Cancer
|
November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Pierre Giglio, Megha Dhamne, Kenneth R Hess, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 16, 2026
Identification of circulating lipidomic biomarkers of malnutrition risk among oncology patients in the Total Cancer Care (TCC) Study: a cross-sectional analysis
Rachel Hoobler, J Alan Maschek, Bai Luo, et al.
The Lancet. Oncology
|
May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO group
Evanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 155) with videos related to
Sort By:
Page
of 16
Oncotarget
|
August 27, 2015
Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting
Veerakumar Balasubramaniyan, Brian Vaillant, Shuzhen Wang, et al.
Biorxiv : the Preprint Server for Biology
|
April 17, 2026
NG2-targeting macrophages inhibit 3D invasion of patient-derived glioblastoma spheroids
Elena Kurudza, Sophia R S Varady, Daniel Greiner, et al.
Journal of Neuro-Oncology
|
August 31, 2012
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme
Kenneth F Grossmann, Howard Colman, Wallace A Akerley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 5, 2006
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma
Christopher E Pelloski, E Lin, Li Zhang, et al.
Stem Cell Research & Therapy
|
October 17, 2015
Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanism
Shuqiang Yuan, Yunxin Lu, Jing Yang, et al.
Cancer Cell
|
October 22, 2011
FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis
Nu Zhang, Ping Wei, Aihua Gong, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 29, 2024
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors
Xuefeng Wang, Tingyi Li, Islam Eljilany, et al.
Cancer
|
November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Pierre Giglio, Megha Dhamne, Kenneth R Hess, et al.
Medrxiv : the Preprint Server for Health Sciences
|
January 16, 2026
Identification of circulating lipidomic biomarkers of malnutrition risk among oncology patients in the Total Cancer Care (TCC) Study: a cross-sectional analysis
Rachel Hoobler, J Alan Maschek, Bai Luo, et al.
The Lancet. Oncology
|
May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO group
Evanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
Page
of 16